what happens if i switch from tirzepatide to semaglutide Switching Tirzepatide: A Provider's Guide Tirzepatide vs. Semaglutide for Weight

[DOI] [PMC free article] [PubMed] [Google Scholar] 86.Monami M., Nreu B., Scatena A., Cresci B., Andreozzi F., Sesti G., Mannucci E

The SURMOUNT-4 trial found that patients who stopped tirzepatide after achieving weight loss experienced LDL increases, triglyceride elevations, and HDL declines within 17 weeks of discontinuation

28,31-35 Trial evidence The LEADER trial examined once-daily liraglutide in patients with established atherosclerotic CVD, chronic kidney disease, heart failure or significant cardiovascular risk factors

Photos, Graphics, and Multimedia Are Not Used Without Permission Only the text of the article is available for republication

PC is considered an essential phospholipid and its administration in preclinical and clinical studies has shown positive effects for reducing steatosis by increasing levels of polyunsaturated fatty acids and reducing the LDL/HDL ratio and TG levels [27,28,29]